+++
title = 'Jubilant Pharmova Ltd:Annual Report 2023-24 Analysis'
date = 2024-08-09 00:01:32
readTime = true
tags = ["Jubilant Pharmova Ltd.", "JUBLPHARMA", "Pharmaceuticals - Diversified", "Healthcare","Mid Cap", "Annual Report", "2023-24"]
showTags = true
toc = true
+++

## Jubilant Pharmova Ltd.: A Comprehensive Overview

### About the Company

**Year of Establishment and Founding History:** Jubilant Pharmova Ltd. was formed as a result of a demerger from Jubilant Life Sciences Limited (now Jubilant Ingrevia Limited) in **2020**. However, the roots of the company trace back much further, to the establishment of Jubilant Organosys Limited in **1978** by Shyam S. Bhartia and Hari S. Bhartia.

**Headquarters Location and Global Presence:** The company's headquarters are located in **Noida, Uttar Pradesh, India**. Jubilant Pharmova has a significant global presence with manufacturing facilities and sales operations across North America, Europe, and Asia.

**Company Vision and Mission:** While publicly stated specific vision and mission statements may not be readily available, Jubilant Pharmova's activities reflect a commitment to providing high-quality pharmaceutical products and services globally. Their focus is on developing and manufacturing pharmaceuticals, radiopharmaceuticals, allergy immunotherapy products, and contract manufacturing services.

**Key Milestones in Their Growth Journey:**

*   **1978:** Jubilant Organosys Limited is established.
*   **2020:** Jubilant Pharmova Limited is formed through demerger.
*   Expansion of manufacturing facilities and product portfolio in various divisions.

**Stock Exchange Listing Details and Market Capitalization:** Jubilant Pharmova Ltd. is listed on the **National Stock Exchange (NSE)** and the **Bombay Stock Exchange (BSE)** under the stock symbol "JUBILANT." Market capitalization fluctuates based on market conditions.

**Recent Financial Performance Highlights:** Refer to the company's latest annual report and quarterly financial results for up-to-date information on revenue, profit, and other key financial metrics.

**Management Team and Leadership Structure:** The company is led by a board of directors and a management team comprising experienced professionals in the pharmaceutical industry.

**Notable Awards or Recognitions:** Jubilant Pharmova and its predecessor companies have received various awards and recognitions for their contributions to the pharmaceutical industry, including awards for safety, environmental performance, and corporate governance.

### Their Products

**Complete Product Portfolio with Categories:**

*   **Pharmaceuticals:** Generics, specialty pharmaceuticals, and active pharmaceutical ingredients (APIs).
*   **Radiopharmaceuticals:** Diagnostic and therapeutic radiopharmaceuticals used in nuclear medicine.
*   **Allergy Immunotherapy:** Allergy extracts and related products for diagnosis and treatment of allergies.
*   **Contract Manufacturing:** Contract manufacturing services for pharmaceutical and biopharmaceutical companies.

**Flagship or Signature Product Lines:**

*   **Radiopharmaceuticals:** Products used in diagnostic imaging and cancer therapy.

**Manufacturing Facilities and Production Capacity:** Jubilant Pharmova operates multiple manufacturing facilities globally, with specific details on production capacity available in company reports and investor presentations.

**Quality Certifications and Standards:** The company adheres to stringent quality standards and holds certifications such as:

*   US FDA
*   EU GMP

**Recent Product Launches or R&D Initiatives:** Refer to the company's latest annual report and presentations for details on recent product launches and ongoing R&D efforts.

### Primary Customers

**Target Industries and Sectors:**

*   Hospitals
*   Diagnostic centers
*   Pharmaceutical companies

**Geographic Markets (domestic vs. international):** Jubilant Pharmova has a significant presence in both domestic (India) and international markets, including North America, Europe, and other parts of Asia.

**Distribution Network and Sales Channels:** The company utilizes a combination of direct sales, distributors, and strategic partnerships to reach its customer base.

### Major Competitors

**Direct Competitors in India and Globally:**

*   **Pharmaceuticals:** Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Cipla, Teva Pharmaceutical Industries, Mylan (Viatris), and others.
*   **Radiopharmaceuticals:** Curium Pharma, GE Healthcare, Siemens Healthineers.

**How they differentiate from competitors:** Jubilant Pharmova focuses on niche areas such as radiopharmaceuticals and allergy immunotherapy, differentiating itself through specialized products and services.

### Future Outlook

**Expansion Plans or Growth Strategy:** Jubilant Pharmova aims to grow through strategic acquisitions, product development, and expansion of its manufacturing facilities.

**Sustainability Initiatives or ESG Commitments:** Refer to the company's sustainability reports or public statements for details on their environmental, social, and governance (ESG) commitments.

**Industry Trends Affecting Their Business:** The pharmaceutical industry is influenced by factors such as:

*   Increasing regulatory scrutiny
*   Globalization of supply chains
*   Technological advancements in drug discovery and manufacturing
*   Growing demand for affordable healthcare

**Long-term Vision and Strategic Goals:** Jubilant Pharmova aims to be a leading global player in its chosen segments, focusing on innovation, quality, and customer satisfaction.

---


{{< rawhtml >}}

<div class="button-container">    
    <a href="https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17acce2d-361c-4ca3-bdad-ef45d680aa62.pdf" target="_blank" class="report-button">
      <i class="fas fa-file-pdf"></i> Download Annual Report
    </a>
</div>
    
{{< /rawhtml >}}
